These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19770758)

  • 1. Combining drugs and radiotherapy: from the bench to the bedside.
    Palanichamy K; Chakravarti A
    Curr Opin Neurol; 2009 Dec; 22(6):625-32. PubMed ID: 19770758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.
    Johannessen TC; Bjerkvig R
    Expert Rev Anticancer Ther; 2012 May; 12(5):635-42. PubMed ID: 22594898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
    Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
    Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards tailored therapy of glioblastoma multiforme.
    Rekers NH; Sminia P; Peters GJ
    J Chemother; 2011 Aug; 23(4):187-99. PubMed ID: 21803695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.
    Nieder C; Mehta MP
    Med Hypotheses; 2011 Mar; 76(3):410-3. PubMed ID: 21112157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.
    Zarnett OJ; Sahgal A; Gosio J; Perry J; Berger MS; Chang S; Das S
    JAMA Neurol; 2015 May; 72(5):589-96. PubMed ID: 25822375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming resistance of glioblastoma to conventional cytotoxic therapies by the addition of PARP inhibitors.
    Chalmers AJ
    Anticancer Agents Med Chem; 2010 Sep; 10(7):520-33. PubMed ID: 20879987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent medical management of glioblastoma.
    Johnson DR; Chang SM
    Adv Exp Med Biol; 2012; 746():26-40. PubMed ID: 22639157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.
    Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP
    Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.
    St-Coeur PD; Touaibia M; Cuperlovic-Culf M; Morin P
    Genomics Proteomics Bioinformatics; 2013 Aug; 11(4):199-206. PubMed ID: 23732626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
    Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
    Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.
    Peereboom DM; Shepard DR; Ahluwalia MS; Brewer CJ; Agarwal N; Stevens GH; Suh JH; Toms SA; Vogelbaum MA; Weil RJ; Elson P; Barnett GH
    J Neurooncol; 2010 May; 98(1):93-9. PubMed ID: 19960228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of unresectable glioblastoma multiforme.
    Nieder C; Grosu AL; Astner S; Molls M
    Anticancer Res; 2005; 25(6C):4605-10. PubMed ID: 16334150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.
    St-Coeur PD; Poitras JJ; Cuperlovic-Culf M; Touaibia M; Morin P
    J Neurooncol; 2015 Oct; 125(1):91-102. PubMed ID: 26311249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme.
    Baumann F; Bjeljac M; Kollias SS; Baumert BG; Brandner S; Rousson V; Yonekawa Y; Bernays RL
    J Neurooncol; 2004; 67(1-2):191-200. PubMed ID: 15072467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma.
    Guo G; Gong K; Puliyappadamba VT; Panchani N; Pan E; Mukherjee B; Damanwalla Z; Bharia S; Hatanpaa KJ; Gerber DE; Mickey BE; Patel TR; Sarkaria JN; Zhao D; Burma S; Habib AA
    Neuro Oncol; 2019 Dec; 21(12):1529-1539. PubMed ID: 31363754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
    Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation.
    Sabbatino F; Fusciello C; Somma D; Pacelli R; Poudel R; Pepin D; Leonardi A; Carlomagno C; Della Vittoria Scarpati G; Ferrone S; Pepe S
    Cytometry A; 2014 Nov; 85(11):953-61. PubMed ID: 25182801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.
    Wu W; Klockow JL; Zhang M; Lafortune F; Chang E; Jin L; Wu Y; Daldrup-Link HE
    Pharmacol Res; 2021 Sep; 171():105780. PubMed ID: 34302977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.